On a corporate action affecting ordinary shares of Cara Therapeutics, Inc. (CARA)

On June 4, 2024, stockholders of Cara Therapeutics, Inc. approved a reverse stock split at a ratio ranging from one-for-four (1:4) to one-for-twelve (1:12). The date of the reverse split will be announced later. For more details, please, refer to the company’s website.

ITS Ltd. will publish separate notices on the procedures undertaken by ITS Ltd. to process this corporate action outlining how trading in these qualified investments will be carried out.